# A Study of 14C JNJ-67953964 in Healthy Adult Male Participants

> **NCT05197062** · PHASE1 · COMPLETED · sponsor: **Janssen Research & Development, LLC** · enrollment: 8 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** 14C-aticaprant

## Key facts

- **NCT ID:** NCT05197062
- **Lead sponsor:** Janssen Research & Development, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-01-14
- **Primary completion:** 2022-03-02
- **Final completion:** 2022-03-02
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2025-04-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05197062

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05197062, "A Study of 14C JNJ-67953964 in Healthy Adult Male Participants". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT05197062. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*